申请人:Zamerton Holdings Limited
公开号:EP2963052A2
公开(公告)日:2016-01-06
This invention is related to medicine and concerns peptides with cytoprotective activity selected from a group that includes Ac-Asp-Glu-OH, H-Asp-Glu-OCH3, H-Asp-Glu-NH - CH2-CH3, H-Val-Asp-Glu-OH, H-Leu-Asp- Glu-OH and H-Ala-Asp-Glu-Arg-OH, Ala-Asp-Glu, Lys-Asp-Glu and Asp-Glu-Gly, with the peptides remaining chemically stable in storage. Also proposed is a pharmaceutical composition containing effective quantities of peptides selected from a group that includes Ac-Asp-Glu-OH, H-Asp-Glu-OCH3, H-Asp-Glu-NH - CH2-CH3, H-Val-Asp-Glu-OH, H-Leu-Asp- Glu-OH and H-Ala-Asp-Glu-Arg-OH, Ala-Asp-Glu, Lys-Asp-Glu or Asp-Glu-Gly.
The pronounced cytoprotective effect makes it possible to use the pharmaceutical composition in the food, cosmetological and pharmaceutical industries.
这项发明涉及医学,涉及具有细胞保护活性的肽,所选肽包括Ac-Asp-Glu-OH、H-Asp-Glu-OCH3、H-Asp-Glu-NH-CH2-CH3、H-Val-Asp-Glu-OH、H-Leu-Asp-Glu-OH和H-Ala-Asp-Glu-Arg-OH、Ala-Asp-Glu、Lys-Asp-Glu和Asp-Glu-Gly,这些肽在储存中保持化学稳定。还提出了一种含有所选肽的药物组合物,该组合物包括Ac-Asp-Glu-OH、H-Asp-Glu-OCH3、H-Asp-Glu-NH-CH2-CH3、H-Val-Asp-Glu-OH、H-Leu-Asp-Glu-OH和H-Ala-Asp-Glu-Arg-OH、Ala-Asp-Glu、Lys-Asp-Glu或Asp-Glu-Gly。显著的细胞保护作用使得可以将该药物组合物用于食品、化妆品和制药行业。